IHC analysis from the HPA database revealed that CALD1 was highly expressed in normal ovarian cells and exhibited strong or moderate expression levels across various types of ovarian malignancies including serous cystadenocarcinoma, mucinous cystadenocarcinoma and endometroid carcinoma of ovary (Fig. 6). The gene discussed is CALD1; the disease is mucinous cystadenocarcinoma.